Back

PRIORiTize-TAVI might predict more than transcatheter aortic valve replacement waiting list priorities

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: New frontiers in treatment of valvular heart diseases Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Petra Bistrovic

University Hospital Dubrava, Zagreb (Croatia)

5 More presentations in this session

Presentation thumbnail
Valvular heart disease and out-of-hospital cardiac arrest
Doctor M. El-Chouli (Roskilde, DK)
Abstract Slides Video
Presentation thumbnail
Periprocedural changes in systolic pulmonary artery pressure in transcatheter aortic valve implantation
Assistant Professor B. Shahim (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Mortality rates in patients undergoing urgent versus elective transcatheter aortic valve replacement: a systematic review and meta-analysis.
Doctor A. Apostolos (London, GB)
Abstract Slides Video
Presentation thumbnail
Emergency interventional treatment of cardiogenic shock due to decompensated aortic stenosis: a systematic review and meta-analysis
Doctor S. Kuehne (Augsburg, DE)
Abstract Slides Video
Presentation thumbnail
Long term outcomes of patients with decompensated aortic stenosis undergoing urgent transcatheter aortic valve implantation: a TAVI-NOR subs-study
Doctor A. Mohamed Ali (Bergen, NO)
Abstract Slides Video

Access the full session

Session thumbnail
New frontiers in treatment of valvular heart diseases

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Remote monitoring and prioritisation for patients awaiting transcatheter aortic valve implantation safely mitigates longer waiting times
thumbnail
Congress Presentation
Comparison of mortality scores performance in transcatheter aortic valve replacement: suiting up to percutaneous intervention.
thumbnail
Congress Presentation
Transcatheter versus surgical aortic valve replacement in lower-risk patients: an updated meta-analysis of randomised controlled trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources